| Product details |
Supply Impact Dates |
Further Details |
ATTORA LA methylphenidate hydrochloride 60 mg modified release capsule bottle AUST R: 408174Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, modified release
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800195055
|
From
29 Oct 2026
to
27 Nov 2026
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
An alternative brand is available.
|
RITALIN LA methylphenidate hydrochloride 20mg modified release capsule bottle AUST R: 82957Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, modified release
Sponsor:
Novartis Pharmaceuticals Australia Pty Ltd
Phone:
0298053555
|
From
10 Nov 2026
to
15 Jan 2027
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
Alternative brands and alternative strengths are available.
|
RUBIFEN LA methylphenidate hydrochloride 60 mg modified release capsules blister pack AUST R: 362234Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
18 Apr 2025
to
30 Nov 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
An alternative brand is available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
ATTORA LA methylphenidate hydrochloride 40 mg modified release capsule bottle AUST R: 408178Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, modified release
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800195055
|
From
08 Oct 2026
to
12 Nov 2026
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack AUST R: 362233Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
03 Jun 2025
to
20 Aug 2026
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
RUBIFEN LA methylphenidate hydrochloride 20 mg modified release capsules blister pack AUST R: 362231Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
25 Aug 2025
to
20 Aug 2026
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack AUST R: 362232Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
10 Jun 2025
to
01 Oct 2026
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
RUBIFEN LA methylphenidate hydrochloride 40 mg modified release capsules blister pack AUST R: 362230Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
13 May 2025
to
21 Oct 2026
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 18 mg modified release tablet bottle AUST R: 370912Active ingredients:
methylphenidate hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
25 Nov 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 27 mg modified release tablet bottle AUST R: 370911Active ingredients:
methylphenidate hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
30 Jan 2027
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 36 mg modified release tablet bottle AUST R: 370900Active ingredients:
methylphenidate hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
25 Sep 2026
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle AUST R: 370899Active ingredients:
methylphenidate hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
25 Sep 2026
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|